An Innovative Controlled Ovarian Hyperstimulation (COH) Protocol That Combines Large Oocyte Availability and Physiologic Estrogenic Environment for Good Prognosis In Vitro Fertilization and Embryo Transfer (IVF-ET) Patients
Phase of Trial: Phase IV
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Acronyms NATOS
- 24 Jul 2017 Planned End Date changed from 1 Sep 2018 to 1 Dec 2018.
- 24 Jul 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.
- 24 Jul 2017 Status changed from not yet recruiting to recruiting.